Targeted Enzyme-Driven Recovery

Promote. Repair. Recover.

InflammEnz® is a proprietary blend of non-animal–derived proteolytic enzymes shown in published medical studies to support the body’s normal inflammatory response and accelerate soft-tissue repair.*

Get a Quote Why InflammEnz® How it Works Read InflammEnz® Clinical Studies
  • Supports Healthy Inflammatory Balance & Tissue Repair*
  • Clinically Evaluated for Faster Soft-Tissue Recovery*
  • 4 Broad-Spectrum Proteolytic Non-Animal Enzymes*
Scroll
Clinical evidence

Clinical Evidence, Built for Credibility

InflammEnz® is supported by published human clinical research evaluating its role in recovery and soft-tissue repair. In a randomized, placebo-controlled, crossover clinical trial conducted in normal, healthy adults, oral supplementation with InflammEnz® was associated with a significant acceleration of soft-tissue wound healing in the majority of participants. Responding subjects demonstrated faster closure times and less visible redness, findings consistent with a healthier inflammatory response and more efficient tissue repair.*

5
Clinical Studies
77%
Response Rate*
17%
Faster Healing*

Beyond controlled wound-healing research, additional published clinical reports in cosmetic and vascular procedure settings describe reduced bruising, swelling, and post-procedure discomfort with InflammEnz® use.*

Read InflammEnz® Clinical Studies

Inflammation Slows Recovery

Inflammation is a necessary and protective biological response that initiates healing after injury, surgery, or physical stress. In its early stages, inflammatory signaling increases blood flow, activates immune cells, and begins the repair process. When properly resolved, this response supports efficient tissue recovery.*

Problems arise when inflammation becomes excessive or prolonged. Accumulation of damaged proteins, fibrin complexes, cellular debris, and excess interstitial fluid can impair microcirculation, increase tissue pressure, and delay the delivery of oxygen and nutrients needed for repair. This can extend swelling, bruising, and discomfort beyond their useful phase, slowing overall recovery.*

Many conventional approaches focus on suppressing inflammatory signals rather than supporting resolution. While symptom relief may be achieved, suppression alone does not assist the body’s natural cleanup and repair processes. Supporting inflammatory resolution by facilitating debris clearance, restoring fluid balance, and normalizing immune signaling is key to completing the healing cycle and returning tissues to healthy function.*

What builds up
  • Inflammatory Mediators
    Cytokines + signaling by-products that prolong discomfort
  • Excess Fibrin + Damaged Proteins
    Sticky debris that slows cleanup and tissue remodeling
  • Fluid Congestion
    Interstitial swelling that restricts circulation and mobility
  • Cellular Debris
    Dead tissue components that overwhelm clearance pathways
The recovery bottleneck
  1. 1
    Inflammation Escalates
    Swelling + bruising + tenderness intensify
  2. 2
    Congestion Forms
    Fibrin + damaged proteins + fluid accumulation
  3. 3
    Clearance Slows
    Microcirculation + lymphatic flow become less efficient
  4. 4
    Recovery is Delayed
    Symptoms persist longer than necessary
When this bottleneck persists, healing takes longer, not because inflammation is “bad,” but because resolution and cleanup can’t keep pace with the load.*

How it Works


Multi-Enzyme Proteolytic Support

Multi-Enzyme Proteolytic Support

  • Protein & Debris Clearance: Alkaline protease and peptidase support the breakdown of damaged proteins and cellular debris that accumulate at sites of tissue stress.*
  • Circulating Enzyme Activity: Orally administered proteolytic enzymes may be absorbed intact, allowing systemic activity beyond the digestive tract.*
  • Resolution-Focused Action: Enzyme activity supports inflammatory resolution rather than suppression, helping tissues progress efficiently through repair phases.*


By supporting the clearance of inflammatory by-products and damaged tissue components, InflammEnz® helps reduce congestion at injury sites and allows normal healing processes to proceed without interruption.*

Cytokine & Immune Modulation

Cytokine & Immune Modulation

  • α-2-Macroglobulin Interaction: Proteolytic enzymes interact with plasma α-2-macroglobulins, supporting the binding and neutralization of excess pro-inflammatory cytokines.*
  • Macrophage Support: Enzyme activity supports macrophage-mediated clearance of immune complexes and tissue debris.*
  • Balanced Immune Signaling: Helps maintain healthy cytokine signaling involved in tissue remodeling and repair.*


Through support of normal immune signaling and cleanup pathways, InflammEnz® helps prevent prolonged or excessive inflammation that can delay tissue recovery.*

Fluid Balance & Tissue Clearance

Fluid Balance & Tissue Clearance

  • Fibrin & Protein Breakdown: Serratiopeptidase, alkaline protease, and peptidase support the breakdown of excess fibrin and damaged proteins that contribute to swelling and tissue congestion.*
  • Capillary & Lymphatic Support: Enzyme activity helps maintain normal capillary permeability and supports lymphatic clearance of excess interstitial fluid.*
  • Microcirculation Optimization: Supports healthy blood flow and delivery of oxygen and nutrients to stressed tissues.*


By supporting normal fluid dynamics and tissue permeability, InflammEnz® helps reduce localized swelling and pressure, creating an environment that supports faster and more comfortable recovery.*

The InflammEnz® Difference

Most approaches to inflammation management focus on suppression (blocking enzymes, dampening immune signals, or masking symptoms) which may interfere with the body’s normal healing cascade. In contrast, InflammEnz® is designed to work with the body’s physiology by supporting the natural resolution phase of inflammation. Its proprietary blend of alkaline protease, bromelain, serratiopeptidase, and peptidase provides broad-spectrum proteolytic activity that helps clear inflammatory by-products, excess fibrin, damaged proteins, and fluid congestion that commonly prolong recovery following trauma, surgery, or intense physical stress.* Rather than inhibiting essential inflammatory signaling, InflammEnz® functions as a biological response support system, enhancing macrophage activity, cytokine balance, microcirculation, and lymphatic clearance, the key processes involved in efficient tissue repair. This resolution-focused approach allows healing to progress without compromising immune function, tissue remodeling, or circulation. Backed by published human clinical studies demonstrating reduced bruising, swelling, discomfort, and faster soft-tissue recovery, InflammEnz® delivers targeted, non-animal–derived enzyme support for real-world recovery demands.*

Figure: Indexed comparison of recovery-support effects based on outcomes reported across published human clinical studies. Values represent relative direction and magnitude across study findings and are not derived from head-to-head clinical trials.

Approach Core Mechanism Impact on Healing Process Key Takeaways
InflammEnz® Multi-enzyme proteolytic support Supports inflammatory resolution, tissue cleanup, fluid balance, and repair Enhances recovery without suppressing normal healing pathways
NSAIDs Enzyme and cytokine inhibition May blunt inflammation but can interfere with tissue repair and immune signaling Symptom suppression; not designed for long-term recovery support
Single-Enzymes Isolated protease activity Limited scope; targets only one aspect of inflammation Narrow activity; less comprehensive recovery support

Why InflammEnz®

InflammEnz® is designed to support the body’s natural inflammatory resolution and tissue repair processes without suppressing normal healing. By combining alkaline protease, bromelain, serratiopeptidase, and peptidase, InflammEnz® addresses multiple contributors to prolonged recovery including inflammatory mediators, fibrin accumulation, damaged proteins, and excess interstitial fluid helping the body clear congestion and progress efficiently through repair. Supported by published human studies demonstrating reduced bruising, swelling, discomfort, and faster soft-tissue recovery, InflammEnz® delivers targeted recovery support for post-surgical, post-trauma, and performance-related applications.*

  • Multi-Enzyme Recovery System: Broad proteolytic activity supports efficient clearance of inflammatory by-products and damaged tissue components*
  • Resolution Without Suppression: Enhances the body’s natural inflammatory balance without blocking essential healing pathways*
  • Clinically Evaluated Performance: Human studies support faster resolution of bruising, swelling, and discomfort during soft-tissue recovery*

References


  1. Fodor, Peter Bela. Personal experience with ultra-sound assist ed lipoplasty. Lipop/asty 14(1):8-12(1997)
  2. Garparotti, Marco. Superficial liposuction yields superior results for most patients. Aesthetic Surgery 17( 1) :64( 1997)
  3. Rohrich, Rod, et al. Preoperative and postoperative manage ment of the body contour patient. Aesthetic Surgery 16(4):218- 223(1996)
  4. Baumiller, M. XXIV FMS World Congress of Sport Medicine. Symposium on Enzyme Therapy in Sporls Injuries. May 29, 1990. P9. Elsevier Science Publishers, Amsterdam (1990)
  5. InflammEnz produced by Enzymes Inc., Kansas City, MO (816)746- 6461
  6. Seifert J, Fanser R, Bruendel W. Absorption of proteolytic enzymes of plant origin from the G.l. tract into the blood and lymph of adult rats. German Journal ofGastro Enterology 17:1(1979)
  7. Seifert J, Seibrecht, et al. Amylase absorption and transport via blood and lymph of adult rats. German Journal of Gastro Enterology 17:1(1979)
  8. Seifert, et al. Quantitative analysis about the absorption of trypsin, chymotrypsin, amylase, papain and pancreatin in the G.I. tract after oral administration. General Physician (Al/gemeinarzt) 19(4) 132-137(1990)
  9. Steffen C, Menzel J, Smolen J. Intestinal absorption of an enzyme mixture (Wobenzyme) labeled with 3H. Acta Medical Austrica G:13 (1979)
  10. La Marre J, et al. Cytokine binding and clearance properties of proteinase-activated a-2 macroglobulin. Laboratory Investigations 65:3-14(1991)
  11. Rahn HD, Kilig M. The action of hydrolytic enzymes in traumaolo­gy. Results after two prospective randomized double blind stud­ies. General Physician 19(4):183-187(1990)
  12. Kleine MW, Pabst H. The effects of an oral enzyme treatment on experimentally induced hematomas. Forum of the Practitioner Volumes 2:27(1988)
  13. Kamede EV. Inflammation and its treatment with hydrolytic enzymes and rutin. Forum of the General Practitioner 9(1981)
  14. Raas, E, Institution of enzyme therapy in traumatology. In MEF (Editor): Systemic Enzyme Therapy 4th Meeting (March 1988) Medipharma relations, Munich 17-18(1988)
  15. Emele JF, Shanamal J, Winbury MM. The analgesic anti-inflammatory activity of papain. Arch, Int; Pharmacyn. Ther. 159:126 {1996}
  16. Larrick JW. Therapeutic Enzymes for cancer, special presenta tion, Biological Response Modifiers Symposium, Tulsa, OK October 1992
  17. Nakahara M. et al.: Intestinal plasminogen proactivator and acti vator after oral administration of proteolytic enzymes. Pharmaceutical Research 17(1967)
  18. lnderst R. Systemic enzyme therapy. Journal of Pharmacy 52 (1992)
  19. Desser L, Rehberger A. Induction of tumor necrosis factor in human peripheral mononuclear calles by proteolytic enzymes. Oncology 47:474(1990)
  20. Yamada KM, Fibrinonectin-Adhesive Glycoproteins. Nature 2 75: 179-184(1987)